Nicholas Hertz

Nicholas is originally from Santa Monica, California. He graduated from UCLA with a B.S. in Biochemistry in 2006, doing research in both a synthetic organic chemistry lab and a biochemistry lab. He then combined his research interests by performing a Ph.D. in chemical biology with Drs. Kevan Shokat and Al Burlingame at UCSF, using chemical genetic techniques to elucidate kinase signaling pathways. In the Tessier-Lavigne lab, Nicholas is interested in identifying and characterizing novel axon-specific caspase cleavage targets that regulate axon degeneration.

Nick since moved on as co-founder and CSO of Mitokinin.